Astellas Pharma (Japan)

2.0k papers and 45.7k indexed citations i.

About

In recent decades, authors affiliated with Astellas Pharma (Japan) have published 2.0k papers, which have received a total of 45.7k indexed citations. Scholars at this organization have produced 655 papers in Molecular Biology, 297 papers in Oncology and 222 papers in Epidemiology on the topics of Urinary Bladder and Prostate Research (126 papers), Diabetes Treatment and Management (116 papers) and Drug Transport and Resistance Mechanisms (95 papers). Their work is cited by papers focused on Molecular Biology (16.5k citations), Epidemiology (5.9k citations) and Oncology (5.7k citations). Authors at Astellas Pharma (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Nature, Science and Proceedings of the National Academy of Sciences. Some of Astellas Pharma (Japan)'s most productive authors include Masao Sasamata, Takashi Usui, Nobuya Matsuoka, Toshiyuki Takasu, Atsuo Tahara, Masayuki Shibasaki, Hidetaka Kamimura, Yoshimasa Imamura, Hiroshi Handa and Yuki Yamaguchi.

In The Last Decade

Fields of papers published by authors at Astellas Pharma (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Astellas Pharma (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Astellas Pharma (Japan) at the time of their publication.

Countries citing scholars working at Astellas Pharma (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Astellas Pharma (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Astellas Pharma (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astellas Pharma (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025